alexa
Reach Us 44-1522-440391
Hypofractionated Stereotactic Radiotherapy for Orbital Metastases: A Case Report and Review of Literature | OMICS International | Abstract
ISSN: 2157-7099

Journal of Cytology & Histology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Hypofractionated Stereotactic Radiotherapy for Orbital Metastases: A Case Report and Review of Literature

Blerina Resuli1*, Roberto Lisi1, Francesca De Felice1, Daniela Musio1 and Vincenzo Tombolini1,2

 

1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Rome 00161, Italy

2Spencer-Lorillard Foundation, Rome 00161, Italy

*Corresponding Author:
Blerina Resuli
Department of Radiotherapy
Policlinico Umberto I
Sapienza University of Rome
Viale Regina Elena 256, 00161, Rome Italy
Tel: +39 06 49973411
Fax: +39 06 49973411
E-mail: [email protected]

Received Date: July 10, 2014; Accepted Date: August 21, 2014; Published Date: August 23, 2014

Citation: Resuli B, Lisi R, De Felice F, Musio D, Tombolini V (2014) Hypofractionated Stereotactic Radiotherapy for Orbital Metastases: A Case Report and Review of Literature. J Cytol Histol 5:273. doi:10.4172/2157-7099.1000273

Copyright: © 2014 Resuli B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Objective: To evaluate the efficacy and clinical outcome of hypofractionated stereotactic radiotherapy (HSRT) in non-small-cell lung cancer (NSCLC) cancer patients with orbital metastasis.
Case report: A 61-year-old man was admitted to the hospital referring right ptosis and dry hacking cough. HSRT was performed for the orbital metastasis followed by chemotherapy with cisplatin (60 mg/m2) and pemetrexed (500 mg/m2) on day 1 every 21 days for 4 cycles and maintenance pemetrexed (500 mg/m2) on day 1 every 21 days. Control TC scan revealed a complete response of the orbital mass.
Conclusion: HSRT should be considered a valid therapeutic alternative in the management of selected patient with orbital metastases.

Keywords

Top